Truvada Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Each film-coated tablet contains 200 mg of emtricitabine and 245 mg of tenofovir disoproxil (equivalent to 300 mg of tenofovir disoproxil fumarate or 136 mg of tenofovir).
Excipient with known effect: Each tablet contains 96 mg lactose monohydrate.
Excipients/Inactive Ingredients: Tablet core: Croscarmellose sodium, Lactose monohydrate, Magnesium stearate (E572), Microcrystalline cellulose (E460), Pregelatinised starch (gluten free).
Film-coating: Glycerol triacetate (E1518), Hypromellose (E464), Indigo carmine aluminium lake (E132), Lactose monohydrate, Titanium dioxide (E171).

emtricitabine + tenofovir

Manufacturer:

Gilead Sciences

Distributor:

DCH Auriga - Healthcare